{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:59:39Z","timestamp":1792191579802,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/pas.0000000000000529","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T12:15:33Z","timestamp":1444306533000},"page":"120-126","source":"Crossref","is-referenced-by-count":142,"title":["Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens"],"prefix":"10.1097","volume":"40","author":[{"given":"Harry C.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon S.","family":"Sheffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen M.","family":"Gown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210131","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":". Challenges and controversies in the diagnosis of mesothelioma: part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"R2-15-20210131","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncy.21342","article-title":". The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.","volume":"121","author":"Paintal","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"R3-15-20210131","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1309\/AJCPP5R2ZJZKCLWN","article-title":". The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.","volume":"135","author":"Monaco","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R4-15-20210131","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jcp.2010.076794","article-title":". FISH assay development for the detection of p16CDKN2A deletion in malignant pleural mesothelioma.","volume":"63","author":"Chung","year":"2010","journal-title":"J Clin Pathol"},{"key":"R5-15-20210131","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":". Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"key":"R6-15-20210131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/PAS.0000000000000176","article-title":". p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma.","volume":"38","author":"Hwang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R7-15-20210131","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1309\/AJCPOATJ9L4GCGDA","article-title":". p16CDKN2A FISH in differentiation of diffuse malignant peritoneal mesothelioma from mesothelial hyperplasia and epithelial ovarian cancer.","volume":"143","author":"Ito","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R8-15-20210131","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":". Diagnostic usefulness of p16CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R9-15-20210131","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5858\/arpa.2012-0108-OA","article-title":". p16 Deletion in sarcomatoid tumors of the lung and pleura.","volume":"137","author":"Tochigi","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R10-15-20210131","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":". The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"R11-15-20210131","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":". Germline BAP1 mutations predispose to malignant mesothelioma.","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"R12-15-20210131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations.","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"key":"R13-15-20210131","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":". High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma.","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R14-15-20210131","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":". BAP1 Immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R15-15-20210131","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","article-title":"The separation of benign and malignant mesothelial proliferations.","volume":"136","author":"Churg","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R16-15-20210131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PAS.0b013e31826ab1c0","article-title":"IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignanct mesothelial proliferations.","volume":"37","author":"Lee","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R17-15-20210131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.10923","article-title":". The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.","volume":"99","author":"Illei","year":"2003","journal-title":"Cancer"},{"key":"R18-15-20210131","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cncr.23413","article-title":". 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.","volume":"114","author":"Onofre","year":"2008","journal-title":"Cancer"},{"key":"R19-15-20210131","doi-asserted-by":"crossref","first-page":"e0119689","DOI":"10.1371\/journal.pone.0119689","article-title":". Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.","volume":"10","author":"Sheffield","year":"2015","journal-title":"PLoS One"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:45:45Z","timestamp":1620967545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201601000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000529","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}